Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: A meta-analysis
- 1 July 2001
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 185 (1), 56-61
- https://doi.org/10.1067/mob.2001.116371
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- TOLTERODINE: SUPERIOR TOLERABILITY THAN AND COMPARABLE EFFICACY TO OXYBUTYNIN IN INDIVIDUALS 50 YEARS OLD OR OLDER WITH OVERACTIVE BLADDER: A RANDOMIZED CONTROLLED TRIALJournal of Urology, 2001
- Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive BladderInternational Urogynecology Journal, 1999
- Quality‐of‐life aspects of the overactive bladder and the effect of treatment with tolterodineBJU International, 1999
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder complianceBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical Evidence of BiasJAMA, 1995
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995
- Standardisation of terminology of lower urinary tract functionNeurourology and Urodynamics, 1988